Alto Neuroscience, Inc.

NYSE:ANRO

Biotechnology

Healthcare
$25.91 +1.84%

+$0.40 today

Market cap
$1.04B
Beta
1.25
P/E (TTM)
-9.8
EPS (TTM)
-$2.26
52W Low $2.15High $28.44

Volume 0.99M

Average 0.34M

Price history

Alto Neuroscience, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+66.73%

Period high

$36.64

Period low

$12.80

Latest

$25.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
SC 13GOct 30, 2026Oct 30, 2026
4Oct 5, 2026Oct 5, 2026
4Oct 1, 2026Oct 1, 2026
8-KAug 27, 2026Aug 27, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
SC 13GJul 27, 2026Jul 27, 2026
SC 13GJul 20, 2026Jul 20, 2026
8-KJul 14, 2026Jul 14, 2026
424B5Jul 14, 2026Jul 14, 2026

Competitors

Who does Alto Neuroscience, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ANRO's filings, answered from its disclosures.

What is the latest ANRO filing?

The latest filing shown is 10-Q dated Nov 10, 2026.

How many recent filings does ANRO have?

Intrinsic Alpha currently shows 20 recent filings for ANRO.